Mostrar registro simples

dc.contributor.authorBakare, Nyashapt_BR
dc.contributor.authorEdwards, Ivor Ralphpt_BR
dc.contributor.authorStergachis, Andypt_BR
dc.contributor.authorPal, Shanthipt_BR
dc.contributor.authorHolmes, Charles B.pt_BR
dc.contributor.authorLindquist, Mariept_BR
dc.contributor.authorDuncombe, Chrispt_BR
dc.contributor.authorDodoo, Alexpt_BR
dc.contributor.authorNovendstern, Joelpt_BR
dc.contributor.authorNwokike, Judept_BR
dc.contributor.authorKuchenbecker, Ricardo de Souzapt_BR
dc.contributor.authorAberg, Judith A.pt_BR
dc.contributor.authorMiller, Veronicapt_BR
dc.contributor.authorStrobos, Jurpt_BR
dc.date.accessioned2019-09-07T02:33:08Zpt_BR
dc.date.issued2011pt_BR
dc.identifier.issn1549-1676pt_BR
dc.identifier.urihttp://hdl.handle.net/10183/198909pt_BR
dc.format.mimetypeapplication/pdfpt_BR
dc.language.isoengpt_BR
dc.relation.ispartofPLoS Medicine. San Francisco. Vol. 8, no. 7 (Jul. 2011), e1001054, 4 p.pt_BR
dc.rightsOpen Accessen
dc.subjectTerapia antirretroviral de alta atividadept_BR
dc.titleGlobal pharmacovigilance for antiretroviral drugs : overcoming contrasting prioritiespt_BR
dc.typeArtigo de periódicopt_BR
dc.identifier.nrb000785432pt_BR
dc.type.originEstrangeiropt_BR


Thumbnail
   

Este item está licenciado na Creative Commons License

Mostrar registro simples